PSA prostate cancer vaccine
Sponsors
Jonsson Comprehensive Cancer Center, University of Chicago, University of Maryland, Baltimore
Conditions
Prostate Cancer
Phase 1
Phase 2
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
CompletedNCT00015977
Start: 2001-11-30End: 2005-01-31Updated: 2014-03-07
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
CompletedNCT00030602
Start: 2000-01-31End: 2001-12-31Updated: 2019-11-05